Annual Shareholders Equity
$1.79 B
+$62.15 M+3.59%
March 31, 2024
Summary
- As of February 9, 2025, TARO annual stockholders equity is $1.79 billion, with the most recent change of +$62.15 million (+3.59%) on March 31, 2024.
- During the last 3 years, TARO annual shareholders equity has risen by +$89.36 million (+5.25%).
Performance
TARO Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Shareholders Equity
$1.79 B
+$13.91 M+0.78%
March 31, 2024
Summary
- As of February 9, 2025, TARO quarterly stockholders equity is $1.79 billion, with the most recent change of +$13.91 million (+0.78%) on March 31, 2024.
- Over the past year, TARO quarterly shareholders equity has increased by +$13.91 million (+0.78%).
Performance
TARO Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
TARO Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.6% | +0.8% |
| 3 y3 years | +5.3% | +5.3% |
| 5 y5 years | -5.9% | -13.1% |
TARO Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -5.0% | at high | -5.4% |
| 5 y | 5-year | -14.8% | -5.0% | -14.8% | -7.5% |
| alltime | all time | -18.7% | -99.9% | -23.5% | -99.9% |
Taro Pharmaceutical Industries Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | $1.79 B(+3.6%) | $1.79 B(+0.8%) |
| Dec 2023 | - | $1.78 B(+1.8%) |
| Sep 2023 | - | $1.75 B(+0.5%) |
| Jun 2023 | - | $1.74 B(+0.4%) |
| Mar 2023 | $1.73 B(+1.1%) | $1.73 B(+1.4%) |
| Sep 2022 | - | $1.71 B(-0.4%) |
| Jun 2022 | - | $1.71 B(+0.1%) |
| Mar 2022 | $1.71 B(+0.5%) | $1.71 B(+0.9%) |
| Dec 2021 | - | $1.70 B(+1.4%) |
| Sep 2021 | - | $1.67 B(+0.9%) |
| Jun 2021 | - | $1.66 B(-2.7%) |
| Mar 2021 | $1.70 B(-19.0%) | $1.70 B(-3.2%) |
| Dec 2020 | - | $1.76 B(+1.8%) |
| Sep 2020 | - | $1.73 B(+2.7%) |
| Jun 2020 | - | $1.68 B(-20.0%) |
| Mar 2020 | $2.10 B(+10.4%) | $2.10 B(+2.0%) |
| Dec 2019 | - | $2.06 B(+1.8%) |
| Sep 2019 | - | $2.03 B(+2.9%) |
| Jun 2019 | - | $1.97 B(+3.3%) |
| Mar 2019 | $1.91 B(-13.6%) | $1.91 B(+3.6%) |
| Dec 2018 | - | $1.84 B(-21.4%) |
| Sep 2018 | - | $2.34 B(+3.0%) |
| Jun 2018 | - | $2.27 B(+3.2%) |
| Mar 2018 | $2.21 B(+6.7%) | $2.21 B(+0.3%) |
| Dec 2017 | - | $2.20 B(-0.1%) |
| Sep 2017 | - | $2.20 B(+2.9%) |
| Jun 2017 | - | $2.14 B(+3.5%) |
| Mar 2017 | $2.07 B(+7.1%) | $2.07 B(+3.6%) |
| Dec 2016 | - | $2.00 B(+4.3%) |
| Sep 2016 | - | $1.91 B(-0.0%) |
| Jun 2016 | - | $1.91 B(-0.9%) |
| Mar 2016 | $1.93 B(+36.8%) | $1.93 B(+9.1%) |
| Dec 2015 | - | $1.77 B(+9.9%) |
| Sep 2015 | - | $1.61 B(+5.6%) |
| Jun 2015 | - | $1.52 B(+8.0%) |
| Mar 2015 | $1.41 B(+39.0%) | $1.41 B(+7.2%) |
| Dec 2014 | - | $1.32 B(+10.0%) |
| Sep 2014 | - | $1.20 B(+10.8%) |
| Jun 2014 | - | $1.08 B(+6.4%) |
| Mar 2014 | $1.02 B(+14.6%) | $1.02 B(+7.5%) |
| Dec 2013 | - | $944.70 M(-8.9%) |
| Sep 2013 | - | $1.04 B(+11.3%) |
| Jun 2013 | - | $931.31 M(+5.1%) |
| Mar 2013 | $886.35 M(+43.2%) | $886.35 M(+5.1%) |
| Dec 2012 | - | $843.39 M(+11.4%) |
| Sep 2012 | - | $756.84 M(+11.2%) |
| Jun 2012 | - | $680.68 M(+10.0%) |
| Mar 2012 | $619.01 M(+9.1%) | $619.01 M(+9.1%) |
| Dec 2011 | $567.26 M(+48.8%) | $567.26 M(+13.7%) |
| Sep 2011 | - | $499.11 M(+9.6%) |
| Jun 2011 | - | $455.41 M(+9.2%) |
| Mar 2011 | - | $417.07 M(+9.4%) |
| Dec 2010 | $381.31 M(+30.2%) | $381.31 M(+28.2%) |
| Sep 2010 | - | $297.51 M(+16.2%) |
| Jun 2010 | - | $256.10 M(-12.6%) |
| Dec 2009 | $292.97 M | $292.97 M(+28.1%) |
| Sep 2009 | - | $228.69 M(+8.3%) |
| Jun 2009 | - | $211.07 M(+6.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2009 | - | $198.59 M(+20.9%) |
| Dec 2008 | $164.22 M(+7.2%) | $164.22 M(-20.3%) |
| Sep 2008 | - | $206.04 M(+60.9%) |
| Dec 2007 | $153.24 M(+207.8%) | - |
| Dec 2006 | $49.78 M(-61.1%) | - |
| Dec 2005 | $128.07 M(-65.2%) | $128.07 M(-66.7%) |
| Sep 2005 | - | $384.14 M(+1.7%) |
| Jun 2005 | - | $377.74 M(+1.0%) |
| Mar 2005 | - | $374.11 M(+1.6%) |
| Dec 2004 | $368.12 M(+6.0%) | $368.12 M(+3.0%) |
| Sep 2004 | - | $357.33 M(+2.1%) |
| Jun 2004 | - | $349.85 M(-2.0%) |
| Mar 2004 | - | $356.92 M(+2.7%) |
| Dec 2003 | $347.40 M(+29.1%) | $347.40 M(+8.5%) |
| Sep 2003 | - | $320.33 M(+5.1%) |
| Jun 2003 | - | $304.92 M(+6.4%) |
| Mar 2003 | - | $286.55 M(+6.5%) |
| Dec 2002 | $269.14 M(+23.3%) | $269.14 M(+7.7%) |
| Sep 2002 | - | $249.91 M(+4.3%) |
| Jun 2002 | - | $239.53 M(+4.9%) |
| Mar 2002 | - | $228.31 M(+4.6%) |
| Dec 2001 | $218.36 M(+334.9%) | $218.36 M(+228.9%) |
| Sep 2001 | - | $66.39 M(+12.3%) |
| Jun 2001 | - | $59.10 M(+13.1%) |
| Mar 2001 | - | $52.26 M(+4.1%) |
| Dec 2000 | $50.21 M(+23.8%) | $50.21 M(+8.2%) |
| Sep 2000 | - | $46.39 M(+5.9%) |
| Jun 2000 | - | $43.81 M(+4.2%) |
| Mar 2000 | - | $42.05 M(+3.7%) |
| Dec 1999 | $40.55 M(+40.8%) | $40.55 M(+22.5%) |
| Sep 1999 | - | $33.10 M(+5.8%) |
| Jun 1999 | - | $31.30 M(+4.7%) |
| Mar 1999 | - | $29.90 M(+3.8%) |
| Dec 1998 | $28.80 M(+5.5%) | $28.80 M(+5.1%) |
| Mar 1998 | - | $27.40 M(+0.4%) |
| Dec 1997 | $27.30 M(+3.8%) | $27.30 M(-0.7%) |
| Sep 1997 | - | $27.50 M(+3.0%) |
| Jun 1997 | - | $26.70 M(+1.5%) |
| Mar 1997 | - | $26.30 M(0.0%) |
| Dec 1996 | $26.30 M(+9.1%) | $26.30 M(+2.3%) |
| Sep 1996 | - | $25.70 M(+3.6%) |
| Jun 1996 | - | $24.80 M(+2.1%) |
| Mar 1996 | - | $24.30 M(+0.8%) |
| Dec 1995 | $24.10 M(+10.6%) | $24.10 M(+10.6%) |
| Dec 1994 | $21.80 M(+23.9%) | $21.80 M(+23.9%) |
| Dec 1993 | $17.60 M(+76.0%) | $17.60 M(+76.0%) |
| Dec 1992 | $10.00 M(+108.3%) | $10.00 M(-4.8%) |
| Sep 1992 | - | $10.50 M(+5.0%) |
| Jun 1992 | - | $10.00 M(+4.2%) |
| Mar 1992 | - | $9.60 M(+100.0%) |
| Dec 1991 | $4.80 M(+152.6%) | $4.80 M(+20.0%) |
| Sep 1991 | - | $4.00 M(+17.6%) |
| Jun 1991 | - | $3.40 M(+47.8%) |
| Mar 1991 | - | $2.30 M(+21.1%) |
| Dec 1990 | $1.90 M(-9.5%) | $1.90 M(+5.6%) |
| Mar 1990 | - | $1.80 M(-14.3%) |
| Dec 1989 | $2.10 M(+40.0%) | $2.10 M(+40.0%) |
| Dec 1988 | $1.50 M(0.0%) | $1.50 M(0.0%) |
| Dec 1987 | $1.50 M | $1.50 M |
FAQ
- What is Taro Pharmaceutical Industries annual stockholders equity?
- What is the all time high annual shareholders equity for Taro Pharmaceutical Industries?
- What is Taro Pharmaceutical Industries annual shareholders equity year-on-year change?
- What is Taro Pharmaceutical Industries quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Taro Pharmaceutical Industries?
- What is Taro Pharmaceutical Industries quarterly shareholders equity year-on-year change?
What is Taro Pharmaceutical Industries annual stockholders equity?
The current annual shareholders equity of TARO is $1.79 B
What is the all time high annual shareholders equity for Taro Pharmaceutical Industries?
Taro Pharmaceutical Industries all-time high annual stockholders equity is $2.21 B
What is Taro Pharmaceutical Industries annual shareholders equity year-on-year change?
Over the past year, TARO annual stockholders equity has changed by +$62.15 M (+3.59%)
What is Taro Pharmaceutical Industries quarterly stockholders equity?
The current quarterly shareholders equity of TARO is $1.79 B
What is the all time high quarterly shareholders equity for Taro Pharmaceutical Industries?
Taro Pharmaceutical Industries all-time high quarterly stockholders equity is $2.34 B
What is Taro Pharmaceutical Industries quarterly shareholders equity year-on-year change?
Over the past year, TARO quarterly stockholders equity has changed by +$13.91 M (+0.78%)